Maxigen Biotech Inc.

TWSE:1783 주식 보고서

시가총액: NT$3.9b

Maxigen Biotech 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ching-Ting Chen

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기3.2yrs
CEO 소유권0.1%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간3.3yrs

최근 관리 업데이트

Recent updates

Maxigen Biotech's (TWSE:1783) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 20
Maxigen Biotech's (TWSE:1783) Shareholders Have More To Worry About Than Only Soft Earnings

Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Mar 28
Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

Apr 22
Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 16
Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Feb 23
The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Feb 02
Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Jan 10
Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

Dec 14
Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Nov 22
If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

CEO 보상 분석

Ching-Ting Chen 의 보수는 Maxigen Biotech 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

NT$155m

Jun 30 2024n/an/a

NT$147m

Mar 31 2024n/an/a

NT$150m

Dec 31 2023n/an/a

NT$166m

Sep 30 2023n/an/a

NT$191m

Jun 30 2023n/an/a

NT$192m

Mar 31 2023n/an/a

NT$163m

Dec 31 2022n/an/a

NT$139m

Sep 30 2022n/an/a

NT$110m

Jun 30 2022n/an/a

NT$99m

Mar 31 2022n/an/a

NT$87m

Dec 31 2021NT$1mNT$540k

NT$88m

보상 대 시장: TW 시장에서 비슷한 규모의 회사에 비해 Ching-Ting 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Ching-Ting 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Ching-Ting Chen

3.2yrs

테뉴어

NT$1,322,000

보상

Ms. Ching-Ting Chen is Institutional Director of TCI Co. Ltd. from June 25, 2024 and serves as Head of Research & Design Center since February 5, 2020. She is General manager of TCI CO., Ltd.She has been...

이사회 구성원

이름위치테뉴어보상소유권
Ching-Ting Chen
GM & Representative Director3yrsNT$1.32m0.11%
NT$ 4.4m
Yung-Hsiang Lin
Chairman of the Board3.3yrs데이터 없음데이터 없음
Tsiu-Yuan Li
Representative Director9.4yrs데이터 없음데이터 없음
Chen-Chen Fu
Representative Director3.3yrs데이터 없음데이터 없음
Song Yuan Liao
Independent Director3.3yrs데이터 없음데이터 없음
Shi-Ming Li
Independent Director3.3yrs데이터 없음데이터 없음
Zeng Zhong Ming
Independent Director3.3yrs데이터 없음데이터 없음
Tsong-Jieh Chiou
Directorno data데이터 없음데이터 없음
Shih-Ming Lai
Directorno data데이터 없음데이터 없음

3.3yrs

평균 재임 기간

경험이 풍부한 이사회: 1783 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.